Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Gardiner Healthcare Acquisitions Corp. Announces Intent to Extend
-
Chardan Capital Markets Starts 4D Molecular Therapeutics (FDMT) at Buy
-
Sonnet BioTherapeutics (SONN) Prices 5M Share Offering at $0.45/sh
-
Sonnet BioTherapeutics Announces $2.25 Million Registered Direct Offering and Concurrent Private Placement
-
Dragonfly Energy Announces Closing of $20.0 Million Underwritten Public Offering and Partial Exercise of Over-Allotment Option
-
Dragonfly Energy Holdings (DFLI) Prices 10M Share Offering at $2/sh
-
Dragonfly Energy Announces Pricing of $20.0 Million Underwritten Public Offering
-
Chardan Capital Markets Starts Zura Bio (ZURA)Buy
-
Dragonfly Energy Speaks at Rho Motion Seminar Series
-
Dragonfly Energy Speaks at Rho Motion Seminar Series
-
TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Maintains ‘Buy’ Rating in Latest Chardan Research Report
-
ANEW MEDICAL (LEAS) to Merge with Redwoods Acquisition Corp (RWOD)
-
ANEW MEDICAL, INC. (OTC: LEAS) and Redwoods Acquisition Corp. (NASDAQ: RWOD) Entered into a Definitive Merger Agreement
-
Zura Bio (ZURA) Completes $80M Financing Deal
-
Zura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual Antagonist
-
TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Maintains ‘Buy’ Rating in Latest Chardan Research Report
-
ANEW MEDICAL, INC. Enters Into Definitive Merger Agreement with Redwoods Acquisition Corp.
-
Gardiner Healthcare Acquisitions Corp. Receives Notice Regarding Late Form 10-Q Filing From The Nasdaq Stock Market LLC
-
Gardiner Healthcare Acquisitions Corp. Announces Intent to Extend
-
Presto (PRST) Unlocks $20M of Cash in PIPE Transaction
-
Presto Unlocks Approximately $20M of Cash in PIPE Transaction
-
Dragonfly Energy Reports First Quarter 2023 Financial Results
-
Tenaya Therapeutics Inc (TNYA) PT Lowered to $23 at Chardan Capital Markets, Keeps 'Buy'
-
Form SC 13D/A Dragonfly Energy Holding Filed by: Chardan NexTech Investments 2 LLC
-
4D Molecular Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Insignia Systems, Inc. Announces First Quarter 2023 Financial Results
-
Dragonfly Energy (DFLI) and Ioneer (IONR) Sign Lithium Supply Agreement
-
Dragonfly Energy and Ioneer Sign Lithium Supply Agreement
-
4D Molecular Therapeutics Inc. (FDMT) Prices Upsized 7.5M Share Offering at $16/sh
-
4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
-
4D Molecular Therapeutics Inc. (FDMT) Announces Proposed $100M Share Offering
-
4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock
-
SunPower Invests in Wolf River Electric, Expanding Solar Footprint in the Midwest
-
Iovance Biotherapeutics to Present at Upcoming Conferences
-
Iovance Biotherapeutics to Present at Upcoming Conferences
-
Gardiner Healthcare Acquisitions Corp. Announces Extension
-
Tenaya Therapeutics to Participate at Chardan's 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
-
TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Differentiated with Focus on Tech-Driven Solutions, Outstanding Customer Service
-
Solid Biosciences to Participate in Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
-
MeiraGTx to Participate in Upcoming Investor Conferences
-
MeiraGTx to Participate in Upcoming Investor Conferences
-
Vor Bio to Participate in Upcoming Investor Conferences
-
Dragonfly Energy Holdings (DFLI) and Airstream Announce Battery Partnership
-
Dragonfly Energy and Airstream Announce Battery Partnership
-
Dragonfly Energy and Airstream Announce Battery Partnership
-
REGENXBIO Announces Presentation at Chardan's 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
-
Sensorion to participate in Chardan’s Annual Genetic Medicines & Cell Therapy Manufacturing Summit and Kempen’s Life Sciences Conference
-
Dragonfly Energy Files Annual Report on Form 10-K and Updates Operating Results for the Fourth Quarter and Year ended December 31, 2022
-
Dragonfly Energy Files Annual Report on Form 10-K and Updates Operating Results for the Fourth Quarter and Year ended December 31, 2022
-
Achilles Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

